MedTexts MedTexts
  • About
  • English
Search

17% ALK Mutation Detected in Lung Adenocarcinoma Genetic Testing, Should Targeted Therapy Continue After One Month of Crizotinib Use and NegativeALK?

For patients with ALK-positive non-small cell lung cancer, targeted therapy is the preferred treatment. However, even if ALK turns negative, it may still be considered to continue using targeted drugs, depending on the patient’s specific condition and doctor’s advice.
  • FAQ
  • Lung Adenocarcinoma
  • Genetic Testing
  • Targeted Drug
One minute to read

Categories

  • FAQ
  • Health
  • Healthcare
  • Medicine
  • Medical
  • Medical Knowledge
  • Health Q&A
  • Common Questions and Answers
  • Parenting
  • Health & Medicine

Series

  • Internal Medicine
  • Otorhinolaryngology
  • Nutrition and Health Care
  • Pediatrics
  • Neurology
  • Surgery
  • Pediatrics Other
  • Ophthalmology
  • Orthopedics
  • Nutrition and Health Department

Tags

  • Pediatrics
  • Otorhinolaryngology
  • Health
  • Child Health
  • Medicine
  • Neurology
  • Medical
  • Tonsillitis
  • Treatment Methods
  • Children's Health
© 2023 - 2024 MedTexts
Powered by Hugo